![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by Staff Writers Rio De Janeiro (AFP) Oct 21, 2020
Brazil's health minister said Tuesday the country would add the Chinese-made CoronaVac vaccine against Covid-19 to its national immunization program, despite a political and diplomatic row over whether to use it. Health Minister Eduardo Pazuello said the federal government had reached a deal with Sao Paulo state, which is helping test and produce the vaccine, to buy 46 million doses to be administered starting in January. "This vaccine will be Brazil's vaccine," in addition to another developed by Oxford University and pharmaceutical firm AstraZeneca, Pazuello told a video meeting of the South American country's 27 governors. "That's our big news. This is going to recalibrate the process" of eventually vaccinating Brazil's population against Covid-19, which has claimed more lives here than any country except the United States. CoronaVac, developed by Chinese pharmaceutical firm Sinovac Biotech, has been caught up in a messy battle in Brazil. Far-right President Jair Bolsonaro had labelled it the vaccine from "that other country," and resisted using it, pushing for the Oxford vaccine instead. Sao Paulo Governor Joao Doria, a top Bolsonaro opponent, meanwhile pushed a deal between Sinovac and Brazil's Butantan Institute to test and produce the vaccine in his state. Doria has touted the vaccine as safe and effective, personally holding press conferences to announce preliminary results from the clinical trials. He and Bolsonaro have also clashed over whether vaccination should be compulsory, as Doria would like. "That vaccine will not be obligatory, period," Bolsonaro said Monday. Both the Sinovac and Oxford vaccines are currently undergoing final-stage clinical trials in Brazil, a top testing ground for vaccine candidates because of its high infection rate. Both still need regulatory approval. Brazil had previously signed a contract for 100 million doses of the Oxford vaccine. But CoronaVac is expected to be available first, after Oxford had to suspend testing in September when a volunteer developed an unexplained illness. Brazil, a country of 212 million people, has registered 5.3 million cases and 155,000 deaths from the novel coronavirus. jhb/bfm
![]() ![]() Europe tightens virus curbs as global cases top 40 million Brussels (AFP) Oct 19, 2020 A raft of European nations including Italy and Belgium took urgent new measures on Monday to combat a second wave of coronavirus infections as the worldwide caseload topped 40 million. The latest global milestone came just hours after the number of people who have died from Covid-19 passed 250,000 in Europe, according to an AFP tally, as the pandemic rampages across much of the continent. Many governments are seeking to avoid the full-on lockdowns imposed in the first wave as they battle to keep ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |